Exagen (XGN) EBT (2018 - 2025)
Historic EBT for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to -$7.1 million.
- Exagen's EBT fell 4093.08% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.0 million, marking a year-over-year decrease of 1240.09%. This contributed to the annual value of -$15.1 million for FY2024, which is 3615.57% up from last year.
- Per Exagen's latest filing, its EBT stood at -$7.1 million for Q3 2025, which was down 4093.08% from -$4.4 million recorded in Q2 2025.
- Exagen's 5-year EBT high stood at -$3.0 million for Q2 2024, and its period low was -$15.1 million during Q4 2022.
- For the 5-year period, Exagen's EBT averaged around -$6.8 million, with its median value being -$6.2 million (2021).
- As far as peak fluctuations go, Exagen's EBT crashed by 12886.12% in 2022, and later soared by 6582.82% in 2023.
- Exagen's EBT (Quarter) stood at -$6.9 million in 2021, then tumbled by 119.79% to -$15.1 million in 2022, then skyrocketed by 63.35% to -$5.5 million in 2023, then skyrocketed by 32.33% to -$3.7 million in 2024, then crashed by 89.01% to -$7.1 million in 2025.
- Its EBT was -$7.1 million in Q3 2025, compared to -$4.4 million in Q2 2025 and -$3.8 million in Q1 2025.